Clinical Trials Logo

Cognitive Impairment clinical trials

View clinical trials related to Cognitive Impairment.

Filter by:

NCT ID: NCT05994391 Completed - Inflammation Clinical Trials

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

COG
Start date: June 3, 2022
Phase: N/A
Study type: Interventional

The potential impact of various dietary ingredients to improve cognitive function, mood, well-being, and overall levels of affects are largely undetermined. The purpose of this study is to determine the effects of a combination of two dietary supplements, Scutellaria baicalensis and Acacia catech, on cognitive function, well-being, mood, cognitive interferences, and inflammation.

NCT ID: NCT05980286 Completed - Aging Clinical Trials

Impact of Musical Improvisation Training on Cognitive Function in Older Adults

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

This project will develop and test the effects and mechanisms of a music improvisation training intervention on self-regulation of older adults with and without MCI. The investigator's overall hypothesis is that improvisation training will lead to improvements in self-regulation, compared to controls, and that improvisation training will be associated with specific changes in prefrontal brain networks and ultimately cognitive engagement.

NCT ID: NCT05939622 Completed - COVID-19 Clinical Trials

Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19

Start date: May 18, 2022
Phase: Phase 4
Study type: Interventional

to assess executive network using resting-state fMRI and patterns of brain activation using task fMRI with a cognitive paradigm, against the background of taking the drug in comparison with placebo in patients with post-COVID asthenic syndrome.

NCT ID: NCT05872646 Completed - Clinical trials for Cognitive Impairment

The Effect of Cognitive Functions on Upper Extremity Functionality in Parkinson's Patients

Start date: February 8, 2018
Phase: N/A
Study type: Interventional

Parkinson's Disease (PD), first described by James Parkinson in 1817, is a progressive movement disorder that develops mainly as a result of the destruction of nigrostriatal dopaminergic neurons. The aim of our study is to determine the effect of cognitive functions on upper extremity functionality in individuals with Parkinson's Disease.

NCT ID: NCT05863065 Completed - Clinical trials for Cognitive Impairment

Personalized Virtual Reality Naturalistic Scenarios in Cognitive Impairment

Start date: January 23, 2023
Phase: N/A
Study type: Interventional

The goal of this feasibility study is to investigate the feasibility of a personalized naturalistic Virtual Reality scenario by assessing motion-sickness effects, engagement, pleasantness, and emotions felt considering a sample of individuals with cognitive impairment resident at the Azienda Pubblica di Servizi alla Persona (APSP) "Margherita Grazioli", a long-term care home in Trento (Italy) in collaboration with the Department of General Psychology - University of Padova (Italy) and the Centre for Health and Wellbeing-Fondazione Bruno Kessler (Italy). The current proof-of-concept and feasibility study is a one-session single-centre trial based on a mixed-methods approach inspired by the Obesity-Related Behavioral Intervention Trials (ORBIT) framework for the design (Phase Ib) of digital interventions and their preliminary testing (Phase IIa).

NCT ID: NCT05856604 Completed - Clinical trials for Cognitive Impairment

Music Therapy for Older Adults With Cognitive Decline Living in Care Homes

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

This research aims to investigate whether the use of music-improvisation therapy for older adult participants can lead to improvements in cognitive ability levels, especially in attentional functions. Very relevant reviews highlight studies that demonstrate the effectiveness of Music Therapy training. However, only a few are based on randomised criteria and structured methodological approaches. This affects the generalizability of findings, as to whether Music Therapy interventions are effective in improving cognitive functions, mood, and quality of life of people with cognitive decline. In order to make a difference, there is a need for more studies that are structured [i] according to rigorous empirical criteria (namely involving random assignment of participants to activity groups), [ii] and that gather scientific evidence, based on both standardized cognitive tests and biomarkers (hormones: Cortisol, or stress hormone, and DHEA or aging hormone; brain signal, EEG; Physiology: Respiratory Sinus Arrhythmia). In this RCT study, the investigator investigated the effect of 4-month music therapy vs Storytelling program for older adults with cognitive decline, living in care homes.

NCT ID: NCT05813353 Completed - Clinical trials for Cognitive Impairment

Pre- and Post TAVI Cognitive Functioning and Intraoperative Carotid Flow Measurements

Start date: July 14, 2021
Phase:
Study type: Observational

Purpose: 1. Measuring and optimize the usability of the BAMCOG (games to measure cognitive functioning) 2. Concurrent validation of BAMCOG with MoCA to see if BAMCOG can serve as a monitoring instrument/screener 3. Determination of carotid flow/cerebral blood flow pre- and post implant of prosthesis of aortic valve by ultrasound doppler measurements

NCT ID: NCT05804981 Completed - Clinical trials for Cognitive Impairment

Early Detection of Cognitive Decline

EDCD
Start date: June 8, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the impact of a brief cognitive screener on provider behavior in patients completing an annual wellness visit (AWV). The main question[s] it aims to answer are: - do appropriate referrals increase for patients using the new screener? - do appropriate diagnostic orders increase for patients using the new screener? Participants will respond to 4 questions about their cognitive abilities as part of a larger AWV protocol. Researchers will compare provider behavior for patients completing AWVs before and after implementation of the new screener to see if referral, diagnostic and prescribing behaviors differ.

NCT ID: NCT05802524 Completed - Clinical trials for Cognitive Impairment

Neurophysiological Evaluation of Residual Cognitive Functions in Patients With Severe Alterations of Consciousness

Start date: June 14, 2020
Phase:
Study type: Observational

Identify potential markers of recovery through event-related potentials (ERPs) in the evolution of altered consciousness with potential ability to discriminate between different conditions of altered state of consciousness. Identify potential markers with prognostic value, in order to identify personalized and specific intensive rehabilitation paths based on the outcome indexes obtained.

NCT ID: NCT05798767 Completed - Clinical trials for Cognitive Impairment

Preoperative Cognitive Impairment Predicts Postoperative Delirium

Start date: February 1, 2022
Phase:
Study type: Observational

Preoperative cognitive impairment (PCI) may increase the incidence of postoperative delirium (POD), yet screening for cognitive impairment is rarely performed. This study hypothesized that Mini-Cog for preoperative cognitive impairment screening predicts postoperative delirium. Elderly patients (65 years or older) attending Henan Provincial People's Hospital during the trial period who required elective thoracic surgery were recruited into the study.